share_log

Candel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Tak Paul Peter

SEC announcement ·  Nov 30, 2023 17:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more